Cryptococcal Meningitis in AIDS
暂无分享,去创建一个
[1] G. Maartens,et al. Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole , 2006, BMC infectious diseases.
[2] L. Mofenson,et al. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. , 2004, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[3] D. Banker,et al. Cryptococcal meningitis in AIDS. , 2002, Indian journal of medical sciences.
[4] Alimuddin Zumla,et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions , 2001, Postgraduate medical journal.
[5] A. Grant,et al. HIV infection and AIDS in the developing world , 2001, BMJ : British Medical Journal.
[6] J. Perfect,et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] R. Herbrecht,et al. Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability , 1999, Transplant infectious disease : an official journal of the Transplantation Society.
[8] M. Saag,et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] F. Diaz,et al. Management of elevated intracranial pressure in patients with Cryptococcal meningitis. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[10] P. Reiss,et al. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS‐associated cryptococcal meningitis , 1997, AIDS.
[11] M. Saag,et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. , 1997, The New England journal of medicine.
[12] K. Tomecki. Cryptococcosis in the era of AIDS 100 years after the discovery of Cryptococcus neoformans , 1997 .
[13] Y. Coovadia,et al. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] S. Jaruratanasirikul. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS. , 1996, The Southeast Asian journal of tropical medicine and public health.
[15] R. Pollard,et al. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] T. G. Mitchell,et al. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans , 1995, Clinical microbiology reviews.
[17] D. Dunt,et al. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] A. Casadevall,et al. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis , 1995, Infection and immunity.
[19] M. Weinstein,et al. Comparison of commercial kits for detection of cryptococcal antigen , 1994, Journal of clinical microbiology.
[20] R. Rozenbaum,et al. Clinical epidemiological study of 171 cases of cryptococcosis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] A. Casadevall,et al. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis , 1993, Journal of clinical microbiology.
[22] M. Saag,et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. , 1992, The New England journal of medicine.
[23] M. Saag,et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. , 1992, The New England journal of medicine.
[24] S. Levitz. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. , 1991, Reviews of infectious diseases.
[25] D. Richman,et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. , 1991, The New England journal of medicine.
[26] D. Ellis,et al. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans , 1990, The Lancet.
[27] A. Forrestel,et al. CRYPTOCOCCOSIS , 1982, The Lancet.
[28] L. Mofenson,et al. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] S. T. Orton,et al. Annual Meeting of the American Neurological Association , 2005, Psychiatric Quarterly.
[30] Thomas S Harrison,et al. Cryptococcal meningitis. , 2004, British medical bulletin.
[31] D. Km,et al. HIV infection and AIDS in the developing world. ABC of AIDS. , 2001 .
[32] M. Saag,et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] M. Saag,et al. Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis , 2000 .
[34] R. Larsen,et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.